Intraarticular therapy with hyaluronic acid and platelet-rich plasma in hip OA – modern aspects
Vol. 29 No. 4 (2021), Review articles
Vol. 29 No. 4 (2021)

Intraarticular therapy with hyaluronic acid and platelet-rich plasma in hip OA – modern aspects

Review articles
https://doi.org/10.35465/29.4.2021.pp53-85
Published December 6, 2021
Lyubomir Sapundzhiev
Department of Propedeutic of Internal Diseases, Medical Faculty, Medical University – Plovdiv, Bulgaria
Tanya Sapundzhieva
Medical University of Plovdiv
Kamen Klinkanov
Department of Propedeutic of Internal Diseases, Medical Faculty, Medical University – Plovdiv, Bulgaria
Anastas Batalov
Department of Propedeutic of Internal Diseases, Medical Faculty, Medical University – Plovdiv, Bulgaria
PDF EN
PDF BG (Български)

Keywords

intraarticular therapy, hip osteoarthritis, hyaluronic acid, platelet-rich plasma

How to Cite

Sapundzhiev, L., Sapundzhieva, T., Klinkanov, K., & Batalov, A. (2021). Intraarticular therapy with hyaluronic acid and platelet-rich plasma in hip OA – modern aspects. Rheumatology (Bulgaria), 29(4), 53-86. https://doi.org/10.35465/29.4.2021.pp53-85
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Intraarticular therapy in ОА, particularly in НОА, is very important, as it is directly targeting the problematic joint, affording stable therapeutic concentrations in situ to be maintained with minimal systemic and adverse effects of the administrated drugs. The presented review consists of 2 parts: descriptive and systematic analysis. In the first part mechanisms of action, indications, contraindications, methods of administration and adverse effects of the intraarticular therapy with hyaluronic acid (IA-HA) and with platelet-rich plasma (IAPRP) are presented, as well as the official statements of the major rheumatologic organizations (EULAR; ACR; OARSI), concerning this issue. In the systemic reviews 34 original studies on IA-НА in  НОА and 7 original studies on IA-PRP in НОА are analysed. The data of rapidity, expression and sustainability of the effects of IA-HA/IA-PRP are assessed by meta analyses, the obtained results are compared to those from the open 8 descriptive and 8 systemic reviews of foreign authors.

In the discussion the different interpretations of the results from the original studies and preceding meta analyses are pointed out according to the authors’ opinion.

https://doi.org/10.35465/29.4.2021.pp53-85
PDF EN
PDF BG (Български)

References

    1. Altman, A.D. et al. The mechanism of action for hyaluronic acid treatment in the osteoarthritik knee: a systematic review.- BMC Musculoskeletal Disorders, 16, 2015, 321, DOI 10.1186/s12891-015-0775-z.
    2. Balazs, E.A., L.J. Denlinger. Viscosupplementation: A new concept in the treatment of osteoarthritis.- J Rheumatol, 20, 1993,(suppl 39):3–9.
    3. George, E. Intra-articular hyaluronan treatment for osteoarthritis.- Ann Rheum Dis, 57, 1998, № 11, 637–640.
    4. Smith, M.M., P. Ghosh. The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the .- Rheumatol Int 7, 1987, 113–22.
    5. Campo, G.M. et al. Hyaluronan reduces inflammation in experimental arthritis by modulating TLR-2 and TLR-4 cartilage expression.- Biochim Biophys Acta, 9, 2011;1812(9):1170–81. doi: 10.1016/j.bbadis.2011.06.006.
    6. Boettger, M.K. et al. Evaluation of long-term antinociceptive properties of stabilized hyaluronic acid preparation (NASHA) in an animal model of repetitive joint pain.- Arthritis Res Ther, 13, 2011,№4, R110.
    7. Prasadam, I., R. Crawford, Y. Xiao. Aggravation of ADAMTS and matrixmetalloproteinase production and role of ERK1/2 pathway in the interaction of osteoarthritic subchondral bone osteoblasts and articular cartilage chondrocytes – possible pathogenic role in osteoarthritis.- J Rheumatol, 39, 2012, № 3, 621–34.
    8. Karlsson, J., L.S. Sjogren, L.S. Lohmander. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study.- Rheumatology (Oxford),41, 2002, 1240–1248.
    9. Maheu, E. et al. Comparative efficacy and safety of two different molecular weight (MW) hyaluronans F60027 and Hylan G-F20 in symptomatic osteoarthritis of the knee (KOA). Results of a non inferiority, prospective, randomized, controlled trial.- Clin Exp Rheumato, 29, l 2011, 527–35.
    10. Pavelka, K.,D. Uebelhart. Efficacy evaluation of highly purified intra-articular hyaluronic acid (Sinovial(R) vs hylan G-F20 [Synvisc(R)]) in the treatment of symptomatic knee steoarthritis. A double-blind, controlled, randomized, parallel-group non-inferiority study.- Osteoarthritis Cartilage, 19, 2011, 1294–300.
    11. Tikiz,C. et al. Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis.- Clin Rheumato, 24, 2005, №3, 244-250.
    12. Van den Bekerom, M.P.J. et al. Viscosupplementation in symptomatic severe hip osteoartritis: A review of the literature and report of 60 patients. - Acta Ortop Belg, 72, 2006,№5, 560-568.
    13. Van den Bekerom, M.P.J.,B. Rys, M. Mulier. Viscosupplementation in the hip: evaluation of hyaluronic acid formulations.- Arch Orthop Trauma Surg, 128, 2008, 275-80.
    14. Berenbaum, F.et al. A randomised, double-blind, controlled trial comparing two intra-articular hyaluronic acid preparations differing by their molecular weight in symptomatic knee osteoarthritis.- Ann Rheum Dis, 71, 2012, №9, 1454–60.
    15. Emmanuel, M., F. Rannou, J.-Y. Reginster. Efficacy and safety of hyaluronic acid in the management of osteoarthritis: Evidence from real-life setting trials and surveys.- Seminars in Arthritis and Rheumatism, 45, 2016, S28–S33.
    16. Reichenbach, S.et al. Hylanversus hyaluronic acid for osteoarthritis of the knee: a systematic review andmeta-analysis.- Arthritis Rheum,57, 2007,1410–8.
    17. Miller, L.E., J.E. Block. US-approved intra-articular hyaluronic acid injections are safe and effective in patients with knee osteoarthritis: systematic review and meta-analysis of randomized, saline-controlled trials. Clin Med Insights Arthritis Musculoskelet Disord, 6, 2013, 57–63.
    18. Atchia,I. et al. Efficacy of a single ultrasound-guided injection for the treatment of hip osteoarthritis.- Annals of the Rheumatic Diseases, 70, 2011, № 1, pp. 110–116.
    19. Zhang, W. et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force ofthe EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). -Ann Rheum Dis,64, 2005,№5, 669-681.
    20. Hochberg, M.C., et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic andpharmacologic therapies in osteoarthritis of the hand, hip, and knee. - Arthritis Care Res (Hoboken), 64, 2012, №4, 465-474.
    21. Zhang, W. et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.- Osteoarthritis Cartilage,16, 2008, №2, 137-62.
    22. Henrotin,Y. et al. Consensus statement on viscosupplementation with hyaluronic acid for the management of osteoarthritis.- Seminars in Arthritis and Rheumatism, 45, 2015, №2, 140–149.
    23. Banuru, R.R. et al. OARSI guidelines for non-surgical management of knee, hip and polyarticular osteoarthritis.- Osteoarthritis and Cartilage, 27,2019, №11, 1578-1589.
    24. Graziani, F. et al. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts.- Clin Oral Implants Res,17, 2006, №2, 212-9.DOI: 10.1111/j.1600-0501.2005.01203.x
    25. Dhurat, R., M. S. Sukesh. Principlles and methods of preparation of platelet-rich plasma: a review and author’s perspective.- Journal of cutaneous and aesthetic surgery, 7, 2014, №4, 189-97.
    26. Fiz, N. et al. Intraosseous Infiltration of Platelet-Rich Plasma for severe Hip Osteoarthritis.- Arthroscopy Techniques, 6, 2017, No 3, e821-e825.
    27. Sundman, E. A. et al. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis.- The American journal of sports medicine, 42, 2014, №1, 35-41.
    28. Dallari, D. et al. Ultrasound-Guided injection of Platelet-rich Plasma and Hyaluronic acid and in Combination, for Hip Osteoarthritis: A randomized Controlled Study.- The American Journal of Sports Medicine, 44, 2016, No. 3DOI: 10.1177/0363546515620383.
    29. Doria, C. et al. Treatment of early hip osteoarthritis: ultrasound-guided platelet-rich plasma versus hyaluronic acid injections in a randomized clinical trial. – Joints, 5, 2017, №3, 152–155.
    30. Kraeutler, M.J. et al. A Double-Blind, Randomized, Controlled Trial Comparing Platelet-Rich Plasma versus Hyaluronic Acid for Early Osteoarthritis of the Hip Joint.- The Jour-nal of Arthroscopie, 35, 2019, №12, Suppl.e16. I:doi.org/10.1016/j.arthro.2019.11.043
    31. Conroizier, T. et al. Viscosupplementation with HANOX-M-XL (Happy- Cross®) is effective in moderate hip osteoarthritis but is not an alternative to hip joint surgery in patients with severe disease: Result of a “real life” clinical survey in 191 patients. Eur. J. Musculoskeletal Dis, 2015, 2, 49-55.
    32. Eymard, F. et al. Predictors of response to viscosupplementation in patients with hip osteoarthritis: results of a prospective, observational, multicenter, open-label, pilot study.- BMC Musculoskeletal Disorders (2017) 18:3 DOI 10.1186/s12891-016-1359-2.
    33. Clementi, D. et al. Efficacy of a single intra-articular injection of ultra-high molecular weight hyaluronic acid for hip osteoarthritis: a randomized controlled study.- European Journal of Orthopaedic Surgery & Traumatology, 28, 2018, 915–922. https://doi.org/10.1007/s00590-017-2083-9.
    34. Lopez, J.C.F., A. Ruano-Ravina. Efficacy and safety of intraarticular hyaluronic acid in the treatment of hip osteoarthritis: a systematic review. - Osteoarthritis Cartilage, 14, 2006, №12, 1306-1311.
    35. Lieberman, J.R. et al. Is intra-articular hyaluronic acid effective in treating osteoarthritis of the hip joint?- J. Arthroplast, 30, 2015, №3,507-11.
    36. Moher, D. et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomized trials.- Journal of Clinical Epidemiology, 63, 2010, №8, e1- e37.
    37. Shamseer, L. et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration andexplanation [published correction appears in BMJ. 2016 Jul 21;354: i4086]. BMJ.2015;350: g7647
    38. Qvistgaard, E. Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline.- Osteoarthritis and Cartilage, 14, 2006, № 2, 163–170.
    39. Spitzer, A.I. et al. Hylan G-F 20 improves hip osteoarthritis: a prospective, randomized study.- Phys Sportsmed, 38, 2010, №2, 35-47.
    40. Crook, P. et al. Efficacy of intra-articular Hyaluronic acid and Cortisone Compared to Cortisone alone for symptomatic Hip Osteoarthritis.- J Arthritis, 8, 2020, № 1, 1000278 ISSN:2167-7921.
    41. Bragantini, A., F. Molinaroli. A pilot clinical evaluation of the treatment of hip osteoarthritis with hyaluronic acid. – Current Therapeutic Research, 55, 1994, №1, 319-330.
    42. Brocq, O. et al. Hip osteoarthritis: short-term efficacy and safety of viscosupplementation by hylan G-F 20. An open –label study of 22 patients. - Joint Bone Spine, 69, 2002, №4, 388-391.
    43. Vad, V.B. et al. Role of Hylan G-F 20 in Treatment of Osteoarthritis of the Hip Joint. - Arch Phys Med Rehabil, 84, 2003, №8,1224-1226.
    44. Conrozier, T. et al. Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open-label, multicentre, pilot study. - Clin Exp Rheumatol, 21, 2003; №5, 605-610.
    45. Conrozier, T. et al. Clinical response to intra-articular injections of hylan G-F 20 in symptomatic hip osteoarthritis; the OMERACT-OARSI criteria applied to the results of a pilot study. - Joint Bone Spine, 73, 2006, №6,705-709.
    46. Conrozier, T et al. Safety, efficacy and predictive factors of efficacy of a single intra-articular injection of non-animal-stabilized hyaluronic-acid in the hip joint: results of a standardized follow-up of patients treated for hip osteoarthritis in daily practice. - Arch Orthop Trauma Surg, 129, 2009, №6, 843-848.
    47. Berg, P., U. Olsson. . Intra-articular injection of non-stabilized hyaluronic acid (NASHA) for osteoarthritis of the hip: a pilot study. - Clin Exp Rheumatol, 22, 2004,№3, 300-306.
    48. Caglar-Yagci, et al. Safety and efficacy of ultrasound guided intra- articular hylan G-F 20 injection in osteoarthritis of the hip: a pilot study. - Rheumatol Int Jun, 25, 2005, №5, 341-344.
    49. Pourbagher, M.A., M. Osalay, A. Pourbagher. Accuracy and outcome of sonographically guided intra-articular sodium hyaluronate injections in patients with osteoarthritis of the hip. - J Ultrasound Med, 24, 2005, №10, 1391-1395.
    50. Gaston, M. S., C. H. Tiemessen, J.E. Philips. Intra-articular hip viscosuplemantation with synthetic hyaluronic acid for osteoarthritis: efficacy, safety and relation to pre-injection radiographs.- Arch.Orthop. Trauma Surg, 127, 2007, №10, 899-903.
    51. Migliore, A. et al. Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. – Osteoarthritis Cartilage, 11, 2003, №4,305-306.
    52. Migliore, A. et al. Repeated ultrasound-guided intra-articular injections of 40 mg of Hyalgan may be useful in symptomatic relief of hip osteoarthritis. - Osteoarthritis Cartilage, 13, 2005,№12,1126-1127.
    53. Migliore, A.et al. Open pilot study of ultrasound guided intra-articular injection of hylan G-F 20 (Synvisk) in the treatment of symptomatic hip osteoarthritis. - Clin Rheumatol, 24, 2005, №3, 285-289.
    54. Migliore, A. et al. The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months’ follow-up. - Clin Rheumatol, 25 2006, №3,389-393.
    55. Migliore, A. et al. Intra-articular administration of hylan G-f 20 in patients with symptomatic hip osteoarthritis: tolerability and effectiveness in a large cohort study in clinical practice. - Curr Med Res Opin, 24, 2008, №5,1309-1316.
    56. Migliore, A. et al. Comparative, double blind, controlled study of intra-articular hyaluronic acid (Hyalubrix ®) injections versus local anesthetics in osteoarthritis of the hip. - Arthritis Res Ther, 11, 2009, №6, R183.
    57. Migliore, A. et al. Intra-articular injection of hyaluronic acid (MW 1,500-2,000 kDa; HyalOne) in symptomatic osteoarthritis of the hip: a prospective cohort study.- Arch Orthop Trauma Surg, 131, 2011, №12, 1677-85.
    58. Renneson-Rey,B. et al. Does joint effusion influence the clinical response to a single Hylan GF-20 injection for hip osteoarthritis.- Joint Bone Spine, 75, 2008, №2, 182-188.
    59. Diracoglu, D. et al. Knee vs hip single –joint intraartcular hyaluronic acid injection in patients with both hip and knee osteoarthritis: a pilot study. Clin Rheumatol, 28, 2009, 28:1021–1024 DOI 10.1007/s10067-009-1199-7.
    60. Richette, P. et al. Effect of hyaluronic acid in symptomatic hip osteoarthritis. A multicenter, randomized, placebo-controled trial. - Arthritis Rheum, 60, 2009 №3, 824-830.
    61. Eyigor, C. Efficacy of intraarticular hyaluronic acid injection trough a lateral approach under fluoroscopic control for advanced hip osteoarthritis. AĞRI 22, 2010, №4,139-144.
    62. Rivera, F. Hip viscosupplementation. - Minerva Ortop Trauma, 62, 2011, №3,145-155.
    63. Sanchez, M. et al. Ultrasound-guided platelet-rich plasma injection for the treatement of osteoarthritis of the hip.- Rheumatology, 51, 2012, №1, 144-150. doi:10.1093/rheumatology/ker303
    64. Battaglia M., et al. Efficacy of Ultrasound-guided Intra-articular injection of Platelet-rich Plasma Versus Hyaluronic Acid for Hip Osteoarthritis. - Orthopedics , 36, 2013, №12, e1501-8.
    65. Di Sante, L. et al. Intra-articular hyaluronic acid vs platelet-rich plasma in the treatment of hip osteoarthritis.- Med Ultrason, 18, 2016, № 4, 463-468, DOI: 10.11152/mu-874.
    66. Brander, V. et al. Evaluation of use of intraarticular injection as a treatment for painful hip osteoarthritis: a randomized, double-blindq multicenter, parallel group study comparing a single 6-ml injection of hylan GF-20 with saline.- Osteoarthritis and Cartilage, 27, 2019, №1, 59-70.
    67. De Lucia, O. et al. Effectiveness and Tolerability of Repeated courses of Viscosuplementation in Symptomatic Hip Osteoarthritis: A retrospective Observational Cohort Study of High Molecular Weight vs. Medium Molecular Weight Hyaluronic Acid vs. No Viscosuplementstion.- Frontiers in Pharmacology, 10, 2019, 1007. doi: 10.3389/fphar.2019.01007.
    68. Singh JR, Haffey P, Valimahomed A, Gellhorn A. The Effectiveness of Autologous Platelet-Rich Plasma for Osteoarthritis of the Hip: A Retrospective Analysis.- Pain Medicine, 20, 2019, № 8, 1611-1618. doi: 10.1093/pm/pnz041.
    69. Conrozier, T., E. Vignon, E. Is there evidence to support the injection of viscosupplemen-tation in the treatment paradigm for patients with hip osteoarthritis? - Clin Exp Rheumatol, 23, 2005, №5, 711-716.
    70. Conrozier, T. Viscosupplementation for Treatment of Knee and Hip Osteoarthritis Pain – Recent Evidence and Considerations for Clinical Practice. - Future Directions in Surgery 2006, 91-95. www.touchbriefings.com/pdf/1816/Conrozier.pdf
    71. Higgins, J.P.T., S. Green. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011).The Cochrane Collaboration. Available from: www.cochranehandbook.org; 2011.
    72. Jadad, A.R. et al. Assessing the Quality of Reports of Randomised Clinical Trials: Is blinding Necessary? - Control Clin Trials, 17, 1996, № 1, 1-12.
    73. Howick, J. et al. OCEMB Oxford 2011Levels of Evidence, Centre for Evidence-Based Medicine, London, UK, 2011.
    74. Atkins, D. et al. Grading quality of evidence and strength of recommendations. - BMJ, 328, 2004, № 7454, 1490. doi: 10.1136/bmj.328.7454.1490
    75. Zhang, W. et al. OARSI recommendations for the management of hip and knee osteoarthritis, part III: Changes of evidence following systematic cumulative update of research published through January 2009.- Osteoarthritis Cartilage, 18, 2010, №4, 476-499. doi: 10.1016/j.joca.2010.01.013.
    76. Colen S, van den Bekerom MP, Bellemans J, Mulier M. Comparison of intra-articular injections of hyaluronic acid and corticosteroid in the treatment of osteoarthritis of the hip in comparison with intra-articular injections of bupivacaine. Design of a prospective, randomized, controlled study with blinding of the patients and outcome assessors. BMC Musculoskelet Disord, 11, 2010, art. №264.
    77. Abate, M. et al. Viscosuplementation with Hyaluronic Acid in Hip Osteoarthritis (a review). Upsala J Med Sci, 113, 2008, №3, 261–178.
    78. Migliore, A. et al. Hylan G-F 20: Review of its Safety and Efficacy in the Management in Joint Pain in Osteoarthritis. - Clin Med Insights Arthritis Musculoskelet Disord, 20, 2010 №3, 55-68.
    79. Rivera, F. Can viscosuplementation be used in the Hip? – Orthopedics, 37, 2014, №1, 48-55. doi: 10.3928/01477447-20131219-08.
    80. Van den Bekerom, M.P. et al. What is the evidence for viscosupplementation in the treatment of patients with hip osteoarthritis? Systematic review of the literature.- Arch Orthop Trauma Surg, 128, 2008, №3, 815–23.
    81. Slaunwhite, E. et al. Hyaluronic acid injection in Patients with Hip Osteoarthritis: A Systematic Review. Austin Arthritis, 1, 2016, №2, 1-5, id1007. www.austinpublishinggroup.com
    82. Piccirilli, E. et al. Viscosuplementation with intra-articular hyaluronic acid for hip disorders. A systematic review and meta-analysis.- Muscles, Ligaments and Tendons Journal, 6, 2016, №3, 293-299.
    83. Leite, V.F., J.E.D. Amareda, A.M. Buhler. Viscosuplementation for Hip Osteoarthritis: A Systematic Review and Meta-Analysis of the Efficacy on Pain and Disability, and the Occurrence of Adverse Events.- Archives of Physical Medicine and Rehabilitation, 99, 2018, №3, 574-83.
    84. Honvo, G. et al. Safety of Hyaluronic Acid Injection in Osteoarthritis: Outcomes of a Systematic Reviews and Meta-analysis.- Drugs & Aging36, 2019, Suppl 1: S101–S127. https://doi.org/10.1007/s40266-019-00657-w.
    85. Liao,Y.Y. et al. Intra-articular Viscosuplementation for patients with Hip Osteoarthritis: A Meta-analysis and Systematic Review. Med Sci Monit, 25, 2019, 6436-6445.
    86. Bei Wu, B., Y.-M. Li, Y.-Ch. Liu. Efficacy of intra-articular hyaluronic acid in hip osteoarthritis: a meta-analysis of randomized controlled trials. Meta-analysis- Oncotarget, 8, 2017, No. 49, 86865-86876. www.impactjournals.com/oncotarget/
    87. Abate, M. Hyaluronic acid and Platelet Rich Plasma in Hip Osteoarthritis.- Surgery Curr Res, 3, 2013, 5. http://dx.doi.org/10.4172/2161-1076.1000e110
    88. Ali, M. et al. The use of ultrasound-guided platelet-rich plasma injections in the treatment of hip osteoarthritis: a systematic review of the literature.- Journal of ultrasonography,18, 2018, 75, 332-337.
    89. Ye, Ye et al. Platelet-rich plasma versus hyaluronic acid in patients with hip osteoarthritis: A meta-analysis of randomized controlled trials.- International Journal of Surgery, 53, 2018, 279–287. doi: 10.1016/j.ijsu.2018.03.078.
    90. Jüni, P., S. Reichenbach, P. Dieppe. Osteoarthritis: rational approach to treating the individual.- Best Pract Res Clin Rheumatol, 20, 2006, №4,721-40.
    91. Kolanski, S.L., et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care & Research Vol. 72, No.2, Feb. 2020, pp149-162. Doi: 10.10002/acr.24131.
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Downloads

Download data is not yet available.